New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Bio-Nutra Technologies Files Suit Against Decas Cranberry Products

LAS VEGAS, NV, OCT. 18, 2006—The patent owner of Cran-Max® cranberry supplement, Bio-Nutra Technologies, LLC, Venice, FL, today announced it has filed a patent infringement and unfair competition suit against Decas Cranberry Products, Inc., and Decas Botanical Synergies, LLC, Wareham, MA., marketer of PACran.

“We believe, based on the manufacturing process, content, and dosage of PACran that it infringes on Bio-Nutra Technologies’ patent,” said Doug Mann, managing director. “In addition, Decas has claimed in its marketing materials, that PACran is the only cranberry supplement clinically studied for urinary tract infections (UTIs). Cran-Max is supported by several clinical studies showing efficacy for UTIs, as early as 1998,” said Mann. “In fact, in some of its product literature, Decas references a cranberry study published in the Canadian Journal of Urology, June 9, 2002, which demonstrated clinical effectiveness. This study was actually conducted using Cran-Max as the cranberry supplement.”

# # #

Tom McCartney
(412) 361-5178
[email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.